| Catalog # |
Product Name |
Authors |
Journal Name |
Article Title |
| H00000673-M02 |
BRAF monoclonal antibody (M02), clone 3D2 |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| H00001398-B01P |
CRK purified MaxPab mouse polyclonal antibody (B01P) |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| H00001399-D01P |
CRKL purified MaxPab rabbit polyclonal antibody (D01P) |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| H00005295-M01 |
PIK3R1 monoclonal antibody (M01), clone 3A10 |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| H00005170-B01P |
PDPK1 purified MaxPab mouse polyclonal antibody (B01P) |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| H00005335-M01 |
PLCG1 monoclonal antibody (M01), clone 2A2 |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| H00000891-D01P |
CCNB1 purified MaxPab rabbit polyclonal antibody (D01P) |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| H00002534-D01P |
FYN purified MaxPab rabbit polyclonal antibody (D01P) |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| PAB12647 |
KDR polyclonal antibody |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| PAB18088 |
YWHAZ polyclonal antibody |
Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. |
Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] |
An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma. |
| H00003954-M03 |
LETM1 monoclonal antibody (M03), clone 6F7 |
Shin JY, Chung YS, Kang B, Jiang HL, Yu DY, Han K, Chae C, Moon JH, Jang G, Cho MH |
Cancer Gene Ther. 2013 Feb 8. doi: 10.1038/cgt.2013.6. |
Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice. |
| H00025855-M01 |
BRMS1 monoclonal antibody (M01), clone 2D4-2G11 |
Liu Y, Mayo MW, Nagji AS, Hall EH, Shock LS, Xiao A, Stelow EB, Jones DR |
Cancer Res. 2013 Feb 15;73(4):1308-17. doi: 10.1158/0008-5472.CAN-12-2489. Epub 2012 Dec 26. |
BRMS1 Suppresses Lung Cancer Metastases through an E3 Ligase Function on Histone Acetyltransferase p300. |
| H00003021-M01 |
H3F3B monoclonal antibody (M01), clone 2D7-H1 |
Orsi GA, Algazeery A, Meyer RE, Capri M, Sapey-Triomphe LM, Horard B, Gruffat H, Couble P, Ait-Ahmed O, Loppin B |
PLoS Genet. 2013 Feb;9(2):e1003285. doi: 10.1371/journal.pgen.1003285. Epub 2013 Feb 7. |
Drosophila Yemanuclein and HIRA Cooperate for De Novo Assembly of H3.3-Containing Nucleosomes in the Male Pronucleus. |
| KA1334 |
MTT Cell Proliferation Assay Kit |
Kats A, Bage T, Georgsson P, Jonsson J, Quezada HC, Gustafsson A, Jansson L, Lindberg C, Nasstrom K, Yucel-Lindberg T |
FASEB J. 2013 Feb 27. |
Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo. |
| H00010544-P01 |
PROCR (Human) Recombinant Protein (P01) |
Fink K, Busch HJ, Bourgeois N, Schwarz M, Wolf D, Zirlik A, Peter K, Bode C, von Zur Muhlen C |
PLoS One. 2013;8(2):e53103. doi: 10.1371/journal.pone.0053103. Epub 2013 Feb 7. |
Mac-1 Directly Binds to the Endothelial Protein C-Receptor: A Link between the Protein C Anticoagulant Pathway and Inflammation? |
| H00009759-P01 |
HDAC4 (Human) Recombinant Protein (P01) |
Isaacs JT, Antony L, Dalrymple SL, Brennen WN, Gerber S, Hammers H, Wissing M, Kachhap S, Luo J, Xing L, Bjork P, Olsson A, Bjork A, Leanderson T |
Cancer Res. 2013 Feb 15;73(4):1386-99. doi: 10.1158/0008-5472.CAN-12-2730. Epub 2012 Nov 13. |
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment. |
| H00007178-M01 |
TPT1 monoclonal antibody (M01), clone 3C7 |
Chen K, Chen S, Huang C, Cheng H, Zhou R |
Biol Cell. 2013 Feb 6. doi: 10.1111/boc.201200080. |
TCTP increases stability of hypoxia-inducible factor 1? by interaction with and degradation of the tumor suppressor VHL. |
| H00029978-M03 |
UBQLN2 monoclonal antibody (M03), clone 5F5 |
Satoh J, Tabunoki H, Ishida T, Saito Y, Arima K |
Neuropathol Appl Neurobiol. 2013 Feb 20. doi: 10.1111/nan.12036. |
Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains. |
| H00003169-M01 |
FOXA1 monoclonal antibody (M01), clone 2D7 |
Kobayashi T, Iwaya K, Moriya T, Yamasaki T, Tsuda H, Yamamoto J, Matsubara O |
BMC Clin Pathol. 2013 Feb 6;13:5. doi: 10.1186/1472-6890-13-5. |
A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer. |
| H00002810-M01 |
SFN monoclonal antibody (M01), clone 3C3 |
Sousa MM, Zub KA, Aas PA, Hanssen-Bauer A, Demirovic A, Sarno A, Tian E, Liabakk NB, Slupphaug G |
PLoS One. 2013;8(2):e55493. doi: 10.1371/journal.pone.0055493. Epub 2013 Feb 6. |
An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells. |
|